A latest accomplishment in the management of schizophrenia has been concluded with FDA Approves Schizophrenia Drug. This is a major milestone for the millions of girls and boys, men and women who became chronic, and at times disabling, illness carriers. Schizophrenia is one of the major psycho diseases with abnormally thinking content and emotional response or other social behaviours and defects and some of signs include disturbances, thought, auditory hallucinations, bizarre beliefs or delusions and other forms of thought and perceptional disorders. Heretofore, there have been a limited number of antipsychotic medications that within years have yielded variable efficacy but which may cause intolerable side effects in some patients.
This latest approval comes with enhanced medical relief that has fewer impacts, a new light of hope to the suffering patient or the sufferers family for they have to endure quite a number of effects of schizophrenia.
What is Schizophrenia? FDA Approves Schizophrenia Drug
Schizophrenia is a serious long-term mental disorder with which today approximately one percent of the population of the earth, or 20 million people, are affected. This disorder usually manifests during early Adulthood, and the effect of Symptoms or level of functioning interfere may vary greatly between clients. The primary symptoms of schizophrenia include:
- Hallucinations: Sensing objects which are not visually interpreted or physically touched.
- Delusions: Delusions are actually unreal thought processes which are frequently of a paranoid or grandiose character.
- Disorganized Thinking: The patient may have excessive slowness of thought processing and therefore when speaking, they may have a very hard time putting their thoughts in order.
- Cognitive Symptoms: Impairment in activities involving memory, attention and decision making.
Today there is still no proven data indicating what triggers schizophrenia; nevertheless, it is inherit, could be inherit and is influence by the environment and chemistry of the human body. Although there is no efficient cure for schizophrenia, its management will improve the standard of living of the people affected in the society. The present treatment is only mostly concerned with antipsychotic therapies in order to effectively reduce particular symptoms but with the side effects of even change in weight, tiredness, and increased risk of diabetes.
FDA Approves Schizophrenia Drug: A game changer
A new addition to the treatment of this form of serious mental illness is that the FDA has recently approved a new drug used to manage schizophrenia. The particular drug under reference here is [insert drug name and ]which had all possible clinical trials carried out towards determination of efficiency and safety of the drug. Observations from clinical trials point to the likely ability of the new drug to offer better respite for schizophrenia symptoms than lasting antipsychotic drugs without side effects.
When it comes to this new drug it tends to act on certain neurotransmitters in the brain associated with schizophrenia for instance dopamine and glutamate. They further explain that this drug struck the balance and regulates the chemicals to enhance stabilization of mood, the reduction of hallucination as well as promotion of improved cognitive functions without the ravaging effects commonly linked to the conventional medicine.
Another advantage is that the drug is to work well in patients who are non responsive to conventional antipsychotics. Schizophrenia patients with a poor course and prognosis, ‘treatment resistant’ accounts for 30% of the community having schizophrenia… This new drug would be beneficial for such people by giving those in this category enhanced prospects of getting better symptom control and hence the quality of life.
How the New Schizophrenia Drug Works
The pharmacodynamics of the new schizophrenia drug differ from that of the conventional antipsychotics. While the majority of antipsychotic drugs work on the dopamine receptors to minimize psychotic behaviour this new drug is different. In particular it deserves the influence of the drug concerning some of the receptors in the different chains of the brain including glutamatergic and serotonergic neurotransmission; these may be related alters in the cognitive and/or affective patterns in schizophrenia.
Through influencing these pathways, it is possible that the new drug may help resolve both positive symptoms of schizophrenia, including hallucinations and delusions, and negative ones, including the lack of motivation and isolation, which are far more challenging to address. Moreover, because it is relatively new in the market, it may also reduce occurrences of side effects such as; tremors and other abnormal movements associated with typical antipsychotic drugs.
Evidences suggest that patients affected with the new drug showed aided severity of symptoms in few weeks of using the treatment. The majority of the participants highlighted; they experience fewer hallucinations, improved cognitive functions and general improve functioning in day to day activities. Most importantly, these improvements were obtain with a lesser proportion of side effects concerning metabolism, which are infamous to most schizophrenia drugs.
Possible advantages for the patient
The approval of this new schizophrenia drug offers several potential benefits for patients and the broader mental health community:
Improved Symptom Management
Since it has been ascertain that the drug influences positive as well as negative symptoms, one could envisage that it might afford more effective management of the given symptoms and bring better stability in the life of patients.
FDA Approves Schizophrenia Drug Fewer Side Effects
This new treatment could revive the belief of instituting lifetime antipsychotic therapy as distinguished from the first generation of antipsychotics which was associate with side effects such as, weight gain and other metabolic syndromes.
Hope for Treatment-Resistant Patients
To those who continue to have poor outcomes to present day medications, the new drug provides a chance to enhance their situation when other drugs do not work for them.
Improved Cognitive Function
Schizophrenia affects the ability to think clearly, and may make functioning throughout the day difficult. Since the side of cognition of the new drug potentially may affect positive patients’ performance at work, school, and in social settings.
Implications of This For Future Mental Health Treatment
This drug has approve by FDA which is a progress in the constant trend towards better treatment of mental health which always affects the lives of those people who suffer from severe diseases such as schizophrenia. The chance of acquiring new treatments is also an advantage for the schizophrenia affect because it addresses the stigmatism of mental illness by offering a better way of handling the clients and improving their quality of life.
Furthermore, this approval marks a victory in the advancement of the right approach to treatment of schizophrenia and other psychiatric disorders since it is a step away from the general standard approaches to patient’s disorder that does not consider the patient. As scientists spend more time creating drugs that act on only certain pathways in the brain, they may begin to fashion mental health treatment that is more accurate, better, and easier to withstand.
It is for this reason that a success of this new drug is clear indication that the future of mental health research must be sustain. Despite great strides that have been made, there is still a lot more that is unknown about the causes of mental illnesses and effective treatment that can help cure the conditions.
Conclusion
Schizophrenia is one of the most devastating of the severe mental disorders for which a new drug has recently gained approval by the FDA. Laying here is the possibility to significantly alter the lives of patients who have to bear with schizophrenia due to the better symptom control, especially less severe side effects with this drug. As the studies of mental health disorders develop, the possibility of using new methods, such as the described one, is a source of new hope for people with mental illnesses and their families.